Changzhou Qianhong Biopharma Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Changzhou Qianhong Biopharma Co.,Ltd.. Fundamentals are ordered by how Changzhou Qianhong Biopharma Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash paid for other investing activities1,649,650,0000.1960162015-06-30historic
Cash from other investing activities1,551,740,0000.18438102015-06-30historic
Other current assets1,117,516,0160.13278342015-06-30historic
Interest receivable15,370,0130.00183582015-06-30historic
Cash from minority shareholders of subsidiaries4,000,0004.8E-41432015-06-30historic
Fair value change gain-309,557-4.0E-52262015-06-30historic
Operating profit155,898,2880.018523122015-06-30historic
Other current liabilities1,278,1541.5E-43162015-06-30historic
Net income131,169,5710.015593362015-06-30historic
Total profit158,105,8870.018793362015-06-30historic
Total comprehensive income131,169,5710.015593572015-06-30historic
Cash paid for dividends, profits or interests97,876,8340.011634022015-06-30historic
Purchases of fixed assets and others112,370,6680.013354052015-06-30historic
Diluted eps00.04672015-06-30historic
Net change in cash54,357,5440.006464812015-06-30historic
Selling expenses61,563,1060.007324862015-06-30historic
Net cashflow from financing activities96,123,1660.011425432015-06-30historic
Long term borrowings27,000,0000.003216292015-06-30historic
Refunds of taxes1,355,9621.6E-46402015-06-30historic
Notes receivable28,441,8870.003386512015-06-30historic
Cash paid for taxes56,336,3070.006697272015-06-30historic
Capital reserve706,613,2240.083967362015-06-30historic
Interests payable283,9383.0E-57412015-06-30historic
Short term borrowings190,000,0000.022587592015-06-30historic
Minority interest23,166,3010.002757672015-06-30historic
Intangible assets85,061,9310.010118532015-06-30historic
Comprehensive income attributable to minority shareholders-1,974,101-2.3E-48952015-06-30historic
Cash inflows from financing activities194,000,0000.023059072015-06-30historic
Minority interests gain-1,974,101-2.3E-49092015-06-30historic
Cash inflows from operating activities526,353,7520.062549402015-06-30historic
Other payables24,130,5110.002879492015-06-30historic
Total liabilities and equity2,445,988,1510.290649582015-06-30historic
Net cash flows from investing activities-218,372,770-0.025959852015-06-30historic
Inventories153,780,0790.0182710372015-06-30historic
Net cash and cash equivalents ending balance199,658,1620.0237210372015-06-30historic
Cash outflows from operating activities351,214,3030.0417311032015-06-30historic
Prepayment14,175,4020.0016811092015-06-30historic
Revenue330,909,0330.0393211102015-06-30historic
Total non-current assets470,815,0950.0559411422015-06-30historic
Fixed assets104,259,7650.0123911842015-06-30historic
Total liabilities282,642,9440.0335811972015-06-30historic
Non-operating loss39,5370.012162015-06-30historic
Total cost of goods sold175,109,0860.0208112252015-06-30historic
Other receivables3,839,5404.6E-412262015-06-30historic
Deferred tax assets1,531,2891.8E-412372015-06-30historic
Payroll payable1,208,1351.4E-412882015-06-30historic
Accounts payable10,999,4760.0013113132015-06-30historic
Financial expenses-42,721,271-0.0050813432015-06-30historic